Pulse Biosciences is developing nsPFA technology for cardiac ablation to treat AFib and for ablating benign thyroid nodules.

an irregular heart rhythm. Wright would need an ablation to stop the AFib and the flutter. And he would need a pacemaker to make sure his heart rate could be corrected if something happened again.

Background: Symptomatic prolonged sinus pauses on termination of atrial fibrillation (AF) are an accepted indication for pacemaker implantation. We evaluated the outcome of AF ablation in patients ...